Sangamo Biosciences (SGMO) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
EPS Growth %: +25.0%
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +25.0%
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q1 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $5.49 million.
GUIDANCE:
Sangamo Biosciences sees FY2016 revenue of $20-25 million, versus the consensus of $22.76 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Cloudastructure restructures preferred stock, issues $1.3M promissory note
- Barclays Starts Healthpeak Properties Inc (DOC) at Equalweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
